Drug intelligence / Profile preview

Tio-Dexiren

Development stage
Unknown
Lead developer
İlko İlaç
Modality
Small Molecules
Administration
Oral
01

Overview

Tio-Dexiren is a fixed-dose combination pharmaceutical product containing dexketoprofen trometamol and thiocolchicoside. Dexketoprofen is a non-steroidal anti-inflammatory drug (NSAID) and the S(+)-enantiomer of ketoprofen, which acts by inhibiting cyclooxygenase enzymes (COX-1 and COX-2) to provide analgesic, anti-inflammatory, and antipyretic effects. Thiocolchicoside is a semi-synthetic sulfur derivative of colchicoside that acts as a muscle relaxant with selective affinity for gamma-aminobutyric acid (GABA) and glycine receptors, where it acts as a competitive antagonist. Marketed by Apeks Pharma and manufactured by İlko İlaç, Tio-Dexiren is indicated for the symptomatic treatment of mild to moderate pain associated with musculoskeletal disorders, including muscle spasms, dysmenorrhea, and toothache. The combination is designed to address both the inflammatory pain and the associated muscular tension in musculoskeletal conditions.

Brand names
Tio-Dexiren
Other names
dexketoprofen + thiocolchicoside
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Tio-Dexiren.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tio-Dexiren.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call